Antibody-drug Conjugates Market Report 2022: Top Players, Countries, Type and Application, Regional Forecast To 2027|ImmunoGen, Seattle Genetics, Roche

Market Insights:

Antibody Drug Conjugates (ADCs) are monoclonal antibodies (mAbs) attached to biologically active drugs by chemical linkers with labile bonds. By combining the unique targeting of mAbs with the cancer-killing ability of cytotoxic drugs, ADCs allow sensitive discrimination between healthy and diseased tissue. North America is the largest market with about 59% market share. Europe is follower, accounting for about 27% market share. The key players are ImmunoGen, Seattle Genetics, Roche, Takeda etc. Takeda is the largest manufacturer with about 57% revenue market share. Market Analysis and Insights: Global Antibody-drug Conjugates Market The global Antibody-drug Conjugates market size is projected to reach US$ 3729.7 million by 2027, from US$ 2734.4 million in 2020, at a CAGR of 4.7% during 2021-2027.

Get Full PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart)  https://www.qyresearch.com/sample-form/form/2978015/global-antibody-drug-conjugates-market

 QY Research offers an encyclopedic study of the global Antibody-drug Conjugates market with holistic insights into vital factors and aspects that impact future market growth. The global Antibody-drug Conjugates market has been analyzed for the forecast period 2022-2028 and historical period 2017-2021. In order to help players to gain comprehensive understanding of the global Antibody-drug Conjugates market and its critical dynamics, the research study provides detailed qualitative and quantitative analysis. Furthermore, readers are offered with complete and thorough research on different regions and segments of the global Antibody-drug Conjugates market. Almost all industry-specific, microeconomic, and macroeconomic factors influencing the global market growth have been analyzed in the report.

With an exhaustive analysis of the competitive landscape, the authors of the Antibody-drug Conjugates market report have made a brilliant attempt to explore key developments, pricing and business tactics, and future plans of leading companies. Besides the Antibody-drug Conjugates market performance of players in terms of revenue and sales, the analysts shed light on their production, areas served, gross margin, and other important factors. In addition, the Antibody-drug Conjugates report helps players to gain an upper hand in the market competition as it deeply analyzes the market positioning, market growth, and product portfolio of their competitors.

Key Players Mentioned in the Global Antibody-drug Conjugates Market Research Report: ImmunoGen
Seattle Genetics
Roche
Takeda

Global Antibody-drug Conjugates Market Segmentation by Product: Adcetris
Kadcyla

Global Antibody-drug Conjugates Market Segmentation by Application:  Breast Cancer
Lymphoma

The report is the best compilation of different types of segmental analysis of the global Antibody-drug Conjugates market conducted from different angles. The pragmatic approach taken by analysts to study various market segments and the top-down and bottom-up approaches adopted to forecast their market sizes make Antibody-drug Conjugates research study unique and accurate. For validation and revalidation of market figures and other findings, reliable primary sources such as technology and innovation directors, MDs, VPs, CEOs, and supply-side and demand-side industry experts were consulted. Secondary sources such as Bloomberg, databases, white papers, press releases, and company reports were used to collect market information and data.

This research study can be used by all participants of the global Antibody-drug Conjugates market as it covers every major and minor aspect of the current and future market competition. Even for stakeholders, it can prove highly beneficial, considering the range of studies offered along with detailed analysis of growth strategies that players are expected to adopt in the coming years. New entrants or players looking to make a foray into the global Antibody-drug Conjugates market can gather useful information and effective advice from the report. On the other hand, established companies can use the Antibody-drug Conjugates report to stay updated about current and future market scenarios and plan out their future business moves.

Reasons to Procure this Report: -

(A) The research would help top administration/policymakers/professionals/product advancements/sales managers and stakeholders in this market in the following ways.

(B) The report provides Antibody-drug Conjugates market revenues at the worldwide, regional, and country-level with a complete analysis to 2028 permitting companies to analyze their market share and analyze projections, and find new markets to aim.

(C) The research includes the Antibody-drug Conjugates market split by different types, applications, technologies, and end-uses. This segmentation helps leaders plan their products and finances based on the upcoming development rates of each segment.

(D) Antibody-drug Conjugates market analysis benefits investors by knowing the scope and position of the market giving them information on key drivers, challenges, restraints, and expansion chances of the market and moderate threats.

(E) This report would help to understand competition better with a detailed analysis and key strategies of their competitors and plan their position in the business.

(F) The study helps evaluate Antibody-drug Conjugates business predictions by region, key countries, and top companies' information to channel their investments.

Key Questions Answered in the Report Include:

(1) This report gives all the information about the industry analysis, revenue, and overview, of this market.

(2) What will be the rate of increase in market size and growth rate by the end of the forecast period?

(3) What are the major global Antibody-drug Conjugates market trends influencing the development of the market?

(4) What are the vital results of SWOT analysis of the major players operating in the Antibody-drug Conjugates market?

(5) What are the potential growth opportunities and threats faced by Major competitors in the market?

(6) What are the market opportunities and threats faced by vendors in the Global Antibody-drug Conjugates market?

Request for customization in Report:  https://www.qyresearch.com/customize-request/form/2978015/global-antibody-drug-conjugates-market

Table of Content

1 Antibody-drug Conjugates Market Overview
1.1 Antibody-drug Conjugates Product Overview
1.2 Antibody-drug Conjugates Market Segment by Type
1.2.1 Adcetris
1.2.2 Kadcyla
1.3 Global Antibody-drug Conjugates Market Size by Type
1.3.1 Global Antibody-drug Conjugates Market Size Overview by Type (2016-2027)
1.3.2 Global Antibody-drug Conjugates Historic Market Size Review by Type (2016-2021)

1.3.2.1 Global Antibody-drug Conjugates Sales Breakdown in Volume by Type (2016-2021)

1.3.2.2 Global Antibody-drug Conjugates Sales Breakdown in Value by Type (2016-2021)

1.3.2.3 Global Antibody-drug Conjugates Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global Antibody-drug Conjugates Forecasted Market Size by Type (2022-2027)

1.3.3.1 Global Antibody-drug Conjugates Sales Breakdown in Volume by Type (2022-2027)

1.3.3.2 Global Antibody-drug Conjugates Sales Breakdown in Value by Type (2022-2027)

1.3.3.3 Global Antibody-drug Conjugates Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Antibody-drug Conjugates Sales Breakdown by Type (2016-2021)
1.4.2 Europe Antibody-drug Conjugates Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific Antibody-drug Conjugates Sales Breakdown by Type (2016-2021)
1.4.4 Latin America Antibody-drug Conjugates Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa Antibody-drug Conjugates Sales Breakdown by Type (2016-2021) 2 Global Antibody-drug Conjugates Market Competition by Company
2.1 Global Top Players by Antibody-drug Conjugates Sales (2016-2021)
2.2 Global Top Players by Antibody-drug Conjugates Revenue (2016-2021)
2.3 Global Top Players Antibody-drug Conjugates Price (2016-2021)
2.4 Global Top Manufacturers Antibody-drug Conjugates Manufacturing Base Distribution, Sales Area, Product Type
2.5 Antibody-drug Conjugates Market Competitive Situation and Trends
2.5.1 Antibody-drug Conjugates Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by Antibody-drug Conjugates Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antibody-drug Conjugates as of 2020)
2.7 Date of Key Manufacturers Enter into Antibody-drug Conjugates Market
2.8 Key Manufacturers Antibody-drug Conjugates Product Offered
2.9 Mergers & Acquisitions, Expansion 3 Antibody-drug Conjugates Status and Outlook by Region
3.1 Global Antibody-drug Conjugates Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global Antibody-drug Conjugates Historic Market Size by Region
3.2.1 Global Antibody-drug Conjugates Sales in Volume by Region (2016-2021)
3.2.2 Global Antibody-drug Conjugates Sales in Value by Region (2016-2021)
3.2.3 Global Antibody-drug Conjugates Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global Antibody-drug Conjugates Forecasted Market Size by Region
3.3.1 Global Antibody-drug Conjugates Sales in Volume by Region (2022-2027)
3.3.2 Global Antibody-drug Conjugates Sales in Value by Region (2022-2027)
3.3.3 Global Antibody-drug Conjugates Sales (Volume & Value), Price and Gross Margin (2022-2027) 4 Global Antibody-drug Conjugates by Application
4.1 Antibody-drug Conjugates Market Segment by Application
4.1.1 Breast Cancer
4.1.2 Lymphoma
4.2 Global Antibody-drug Conjugates Market Size by Application
4.2.1 Global Antibody-drug Conjugates Market Size Overview by Application (2016-2027)
4.2.2 Global Antibody-drug Conjugates Historic Market Size Review by Application (2016-2021)

4.2.2.1 Global Antibody-drug Conjugates Sales Breakdown in Volume, by Application (2016-2021)

4.2.2.2 Global Antibody-drug Conjugates Sales Breakdown in Value, by Application (2016-2021)

4.2.2.3 Global Antibody-drug Conjugates Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global Antibody-drug Conjugates Forecasted Market Size by Application (2022-2027)

4.2.3.1 Global Antibody-drug Conjugates Sales Breakdown in Volume, by Application (2022-2027)

4.2.3.2 Global Antibody-drug Conjugates Sales Breakdown in Value, by Application (2022-2027)

4.2.3.3 Global Antibody-drug Conjugates Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Antibody-drug Conjugates Sales Breakdown by Application (2016-2021)
4.3.2 Europe Antibody-drug Conjugates Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific Antibody-drug Conjugates Sales Breakdown by Application (2016-2021)
4.3.4 Latin America Antibody-drug Conjugates Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa Antibody-drug Conjugates Sales Breakdown by Application (2016-2021) 5 North America Antibody-drug Conjugates by Country
5.1 North America Antibody-drug Conjugates Historic Market Size by Country
5.1.1 North America Antibody-drug Conjugates Sales in Volume by Country (2016-2021)
5.1.2 North America Antibody-drug Conjugates Sales in Value by Country (2016-2021)
5.2 North America Antibody-drug Conjugates Forecasted Market Size by Country
5.2.1 North America Antibody-drug Conjugates Sales in Volume by Country (2022-2027)
5.2.2 North America Antibody-drug Conjugates Sales in Value by Country (2022-2027) 6 Europe Antibody-drug Conjugates by Country
6.1 Europe Antibody-drug Conjugates Historic Market Size by Country
6.1.1 Europe Antibody-drug Conjugates Sales in Volume by Country (2016-2021)
6.1.2 Europe Antibody-drug Conjugates Sales in Value by Country (2016-2021)
6.2 Europe Antibody-drug Conjugates Forecasted Market Size by Country
6.2.1 Europe Antibody-drug Conjugates Sales in Volume by Country (2022-2027)
6.2.2 Europe Antibody-drug Conjugates Sales in Value by Country (2022-2027) 7 Asia-Pacific Antibody-drug Conjugates by Region
7.1 Asia-Pacific Antibody-drug Conjugates Historic Market Size by Region
7.1.1 Asia-Pacific Antibody-drug Conjugates Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific Antibody-drug Conjugates Sales in Value by Region (2016-2021)
7.2 Asia-Pacific Antibody-drug Conjugates Forecasted Market Size by Region
7.2.1 Asia-Pacific Antibody-drug Conjugates Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Antibody-drug Conjugates Sales in Value by Region (2022-2027) 8 Latin America Antibody-drug Conjugates by Country
8.1 Latin America Antibody-drug Conjugates Historic Market Size by Country
8.1.1 Latin America Antibody-drug Conjugates Sales in Volume by Country (2016-2021)
8.1.2 Latin America Antibody-drug Conjugates Sales in Value by Country (2016-2021)
8.2 Latin America Antibody-drug Conjugates Forecasted Market Size by Country
8.2.1 Latin America Antibody-drug Conjugates Sales in Volume by Country (2022-2027)
8.2.2 Latin America Antibody-drug Conjugates Sales in Value by Country (2022-2027) 9 Middle East and Africa Antibody-drug Conjugates by Country
9.1 Middle East and Africa Antibody-drug Conjugates Historic Market Size by Country
9.1.1 Middle East and Africa Antibody-drug Conjugates Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa Antibody-drug Conjugates Sales in Value by Country (2016-2021)
9.2 Middle East and Africa Antibody-drug Conjugates Forecasted Market Size by Country
9.2.1 Middle East and Africa Antibody-drug Conjugates Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Antibody-drug Conjugates Sales in Value by Country (2022-2027) 10 Company Profiles and Key Figures in Antibody-drug Conjugates Business
10.1 ImmunoGen
10.1.1 ImmunoGen Corporation Information
10.1.2 ImmunoGen Introduction and Business Overview
10.1.3 ImmunoGen Antibody-drug Conjugates Sales, Revenue and Gross Margin (2016-2021)
10.1.4 ImmunoGen Antibody-drug Conjugates Products Offered
10.1.5 ImmunoGen Recent Development
10.2 Seattle Genetics
10.2.1 Seattle Genetics Corporation Information
10.2.2 Seattle Genetics Introduction and Business Overview
10.2.3 Seattle Genetics Antibody-drug Conjugates Sales, Revenue and Gross Margin (2016-2021)
10.2.4 Seattle Genetics Antibody-drug Conjugates Products Offered
10.2.5 Seattle Genetics Recent Development
10.3 Roche
10.3.1 Roche Corporation Information
10.3.2 Roche Introduction and Business Overview
10.3.3 Roche Antibody-drug Conjugates Sales, Revenue and Gross Margin (2016-2021)
10.3.4 Roche Antibody-drug Conjugates Products Offered
10.3.5 Roche Recent Development
10.4 Takeda
10.4.1 Takeda Corporation Information
10.4.2 Takeda Introduction and Business Overview
10.4.3 Takeda Antibody-drug Conjugates Sales, Revenue and Gross Margin (2016-2021)
10.4.4 Takeda Antibody-drug Conjugates Products Offered
10.4.5 Takeda Recent Development 11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Antibody-drug Conjugates Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Antibody-drug Conjugates Industrial Chain Analysis
11.4 Antibody-drug Conjugates Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints 12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Antibody-drug Conjugates Distributors
12.3 Antibody-drug Conjugates Downstream Customers 13 Research Findings and Conclusion 14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach

14.1.1.1 Research Programs/Design

14.1.1.2 Market Size Estimation

14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source

14.1.2.1 Secondary Sources

14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer

Buy Now This Report Click Here: https://www.qyresearch.com/settlement/pre/94306c72e81387e724a7ac6b783f1c26,0,1,global-antibody-drug-conjugates-market

Contact US:
QY Research, INC.
17890 Castleton,
Suite 218,
City of industry, CA - 91748
USA: +1 626 295 2442
Email: enquiry@qyresearch.com
Web: http://www.qyresearch.com

About Us:

QY Research established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), expert's resources (included energy automotive chemical medical ICT consumer goods etc."

This release was published on openPR.